RecruitingNot ApplicableNCT06938971

Randomized Controlled Trial of the Effects of Combined Resistance and AerobiC Exercise on Health-related Quality of Life in Patients Undergoing First-line Chemotherapy for Metastatic Colorectal Cancer (REACH)

Effects of Exercise Training on Health-related Quality of Life in Patients With Unresectable Metastatic Colorectal Cancer: A Multi-center Randomized Controlled Trial


Sponsor

Rigshospitalet, Denmark

Enrollment

150 participants

Start Date

May 16, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

The primary objective of this trial is to compare the effects of 18 weeks structured exercise training versus on control on healt-related quality of life in patients with unresectable mCRC.


Eligibility

Min Age: 18 Years

Inclusion Criteria1

  • \- Adults (≥18 years of age) schduled to undergo chemotherapy for the treatment of unresectable metastatic colorectal cancer.

Exclusion Criteria6

  • Pregnancy.
  • A life expectancy of \< 6 months.
  • Absolute contraindications to maximal exercise, as per the recommendations by the Danish Society of Cardiology.
  • ECOG (Eastern Cooperative Oncology Group) performance status \> 2.
  • Inability to understand the Danish or English language.
  • Engagement in structured moderate-to-high aerobic exercise training for \>30 min \>1 times/week for the past 3 months at the time of inclusion.

Interventions

OTHERExercise training

Participants allocated to the exercise intervention group will receive standard care plus an exercise intervention. The exercise intervention will consist moderate-to-high intensity supervised and unsupervised home-based exercise training (bicyling, walking, or running) 5 times/week for 18 weeks.


Locations(4)

Centre for Physical Activity Research, Copenhagen Univerisity Hospital - Rigshospitalet

Copenhagen, Denmark

Herlev and Gentofte Hospital

Herlev, Denmark

North Zealand University Hospital, Hillerød

Hillerød, Denmark

Zealand University Hospital, Roskilde

Roskilde, Denmark

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06938971


Related Trials